跳至主要内容
临床试验/ISRCTN81574253
ISRCTN81574253已完成未知

Brain development, brain functioning, growth and metabolic aspects in the clinical management of transsexual adolescents

Vrije University Medical Centre (VUMC) (The Netherlands)0 个研究点目标入组 264 人开始时间: 2007年5月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
264

研究概览

简要总结

Abstract results in http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17074986 2017 Results article in https://pubmed.ncbi.nlm.nih.gov/28419243/ (added 06/08/2021) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32909025/ (added 06/08/2021) 2013 Results article in https://pubmed.ncbi.nlm.nih.gov/23433223/ (added 06/08/2021) 2015 Results article in https://pubmed.ncbi.nlm.nih.gov/25720349/ (added 06/08/2021) 2016 Results article in https://pubmed.ncbi.nlm.nih.gov/27318023/ (added 06/08/2021)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Inclusion criteria - pubertal patients:
  • 1. Girls and boys with transsexualism who are eligible for sex reassignment according to psychologist and psychiatrist (if they are older than 12 years, psychologically stable and live in a stable social environment)
  • 2. Girls have to be in stage B2 and boys in G2-G3 with measurable oestradiol and testosterone levels respectively
  • Inclusion criteria - pre-pubertal patients:
  • 1. Girls and boys with high probability of transsexualism according to psychologist or psychiatrist and the age of 9 to 12 years
  • 2. Girls have to be in an earlier stage than B2 and boys in an earlier stage than G2-G3
  • Inclusion criteria - healthy subjects:
  • 1. Girls and boys who are similar aged friends of the transsexual patients

排除标准

  • Exclusion criteria - patients:
  • 1. Intersex conditions
  • Exclusion criteria - healthy subjects:
  • 1. Puberty delaying treatment or hormonal therapy; oral anticonception users are not excluded

研究者

发起方
Vrije University Medical Centre (VUMC) (The Netherlands)

相似试验